Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmuneID is a precision immunology company that utilizes a proprietary platform to map the human immune system with unprecedented resolution. The company's aiSIGHT platform combines high-throughput DNA-display technology with advanced bioinformatics to identify the specific targets of antibodies in patient samples. By decoding these immune responses, ImmuneID aims to discover and develop novel therapies for severe allergies, autoimmune disorders, and inflammatory diseases. The company's approach allows for the identification of disease-driving pathways and the stratification of patients for more effective, personalized treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immune Disease Research.